Published in Drugs on January 01, 2007
Synthesis of chiral N-phosphinyl α-imino esters and their application in asymmetric synthesis of α-amino esters by reduction. Beilstein J Org Chem (2014) 0.78
The treatment of type 2 diabetes in the presence of renal impairment: what we should know about newer therapies. Clin Pharmacol (2016) 0.77
Efficacy and safety of insulin lispro in geriatric patients with type 2 diabetes: a retrospective analysis of seven randomized controlled clinical trials. Aging Clin Exp Res (2014) 0.75
Febuxostat. Drugs (2008) 2.78
Trastuzumab: a pharmacoeconomic review of its use in early breast cancer. Pharmacoeconomics (2008) 2.04
Liposomal amphotericin B: a review of its use as empirical therapy in febrile neutropenia and in the treatment of invasive fungal infections. Drugs (2009) 1.59
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs (2009) 1.56
Meropenem: a review of its use in the treatment of serious bacterial infections. Drugs (2008) 1.51
Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs (2011) 1.47
Olmesartan medoxomil: in children and adolescents with hypertension. Drugs (2010) 1.44
Imidapril: a review of its use in essential hypertension, Type 1 diabetic nephropathy and chronic heart failure. Drugs (2007) 1.44
Albumin-bound Paclitaxel: in metastatic breast cancer. Drugs (2006) 1.42
Gadofosveset. Drugs (2006) 1.42
Sumatriptan fast-disintegrating/rapid-release tablets. Drugs (2006) 1.39
Delapril/manidipine. Drugs (2006) 1.38
Blonanserin: a review of its use in the management of schizophrenia. CNS Drugs (2010) 1.30
Asenapine. CNS Drugs (2009) 1.29
Atomoxetine: a review of its use in attention-deficit hyperactivity disorder in children and adolescents. Paediatr Drugs (2009) 1.27
Pegylated liposomal doxorubicin: a review of its use in metastatic breast cancer, ovarian cancer, multiple myeloma and AIDS-related Kaposi's sarcoma. Drugs (2011) 1.25
Pioglitazone: a review of its use in type 2 diabetes mellitus. Drugs (2006) 1.23
Buprenorphine/naloxone: a review of its use in the treatment of opioid dependence. Drugs (2009) 1.22
Ropivacaine: a review of its use in regional anaesthesia and acute pain management. Drugs (2005) 1.19
Zolpidem: a review of its use in the management of insomnia. CNS Drugs (2005) 1.18
Trastuzumab: A review of its use as adjuvant treatment in human epidermal growth factor receptor 2 (HER2)-positive early breast cancer. Drugs (2010) 1.17
Daptomycin. Drugs (2004) 1.12
Insulin glargine: an updated review of its use in the management of diabetes mellitus. Drugs (2003) 1.11
Memantine: a review of its use in Alzheimer's disease. Drugs (2006) 1.10
Paroxetine controlled release. CNS Drugs (2004) 1.10
Olmesartan medoxomil: a review of its use in the management of hypertension. Drugs (2008) 1.09
Imiquimod: in superficial basal cell carcinoma. Am J Clin Dermatol (2005) 1.08
Zoster vaccine (Zostavax): a review of its use in preventing herpes zoster and postherpetic neuralgia in older adults. Drugs Aging (2010) 1.08
Afatinib: first global approval. Drugs (2013) 1.07
Zoledronic acid : a review of its use in the management of bone metastases of malignancy. Drugs (2008) 1.07
Methoxy polyethylene glycol-epoetin beta: a review of its use in the management of anaemia associated with chronic kidney disease. Drugs (2008) 1.04
Deferasirox : a review of its use in the management of transfusional chronic iron overload. Drugs (2007) 1.02
Pranlukast: a review of its use in the management of asthma. Drugs (2003) 1.02
Dalfampridine extended release: in multiple sclerosis. CNS Drugs (2010) 1.02
Raltegravir. Drugs (2008) 1.01
Polyethylene glycol-liposomal doxorubicin: a review of its use in the management of solid and haematological malignancies and AIDS-related Kaposi's sarcoma. Drugs (2002) 0.99
Famciclovir: a review of its use in herpes zoster and genital and orolabial herpes. Drugs (2006) 0.99
Sorafenib: in hepatocellular carcinoma. Drugs (2008) 0.98
Levobupivacaine: a review of its use in regional anaesthesia and pain management. Drugs (2010) 0.97
Remifentanil : a review of its analgesic and sedative use in the intensive care unit. Drugs (2006) 0.97
Omega-3 ethylester concentrate: a review of its use in secondary prevention post-myocardial infarction and the treatment of hypertriglyceridaemia. Drugs (2009) 0.97
Varenicline: a pharmacoeconomic review of its use as an aid to smoking cessation. Pharmacoeconomics (2010) 0.97
Fenofibrate: a review of its use in dyslipidaemia. Drugs (2011) 0.97
Oxycodone/Naloxone prolonged-release: a review of its use in the management of chronic pain while counteracting opioid-induced constipation. Drugs (2014) 0.97
Basiliximab: a review of its use as induction therapy in renal transplantation. Drugs (2003) 0.96
Pirfenidone: a review of its use in idiopathic pulmonary fibrosis. Drugs (2015) 0.96
Esomeprazole: a review of its use in the management of gastric acid-related diseases in adults. Drugs (2008) 0.96
Pegaptanib: in exudative age-related macular degeneration. Drugs (2005) 0.96
Lutropin alfa. Drugs (2008) 0.96
Trametinib: first global approval. Drugs (2013) 0.95
Adalimumab: in Crohn's disease. BioDrugs (2007) 0.95
Rabbit antithymocyte globulin (thymoglobulin): a review of its use in the prevention and treatment of acute renal allograft rejection. Drugs (2009) 0.94
Glatiramer acetate: a review of its use in relapsing-remitting multiple sclerosis and in delaying the onset of clinically definite multiple sclerosis. Drugs (2010) 0.94
Bosentan: a review of its use in pulmonary arterial hypertension and systemic sclerosis. Am J Cardiovasc Drugs (2006) 0.94
Pneumococcal polysaccharide protein D-conjugate vaccine (Synflorix; PHiD-CV). Paediatr Drugs (2009) 0.94
Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis. Drugs (2002) 0.93
Moxonidine: a review of its use in essential hypertension. Drugs (2006) 0.93
Memantine: a pharmacoeconomic review of its use in moderate-to-severe Alzheimer's disease. Pharmacoeconomics (2005) 0.93
Maraviroc. Drugs (2007) 0.92
Ziprasidone: a review of its use in schizophrenia and schizoaffective disorder. Drugs (2002) 0.92
Octreotide long-acting release (LAR): a review of its use in the management of acromegaly. Drugs (2010) 0.92
Rasagiline: a review of its use in the management of Parkinson's disease. Drugs (2007) 0.91
Cevimeline. Drugs (2008) 0.91
Etanercept: a review of its use in the management of rheumatoid arthritis. Drugs (2007) 0.91
Duloxetine: a review of its use in the treatment of generalized anxiety disorder. CNS Drugs (2009) 0.91
Nelfinavir: a review of its use in the management of HIV infection. Drugs (2005) 0.91
Escitalopram: a review of its use in the management of major depressive disorder in adults. CNS Drugs (2010) 0.90
Micafungin: a review of its use in the prophylaxis and treatment of invasive Candida infections in pediatric patients. Paediatr Drugs (2009) 0.90
Tacrolimus: in heart transplant recipients. Drugs (2006) 0.90
Liraglutide: a review of its use in type 2 diabetes mellitus. Drugs (2009) 0.90
Budesonide/formoterol: a review of its use as maintenance and reliever inhalation therapy in asthma. Drugs (2007) 0.90
Tolcapone: a review of its use in the management of Parkinson's disease. CNS Drugs (2005) 0.89
Raloxifene: a review of its use in the prevention of invasive breast cancer. Drugs (2008) 0.89
Pomalidomide: first global approval. Drugs (2013) 0.88
Extended-release intramuscular naltrexone (VIVITROL®): a review of its use in the prevention of relapse to opioid dependence in detoxified patients. CNS Drugs (2013) 0.88
Budesonide/formoterol: a review of its use in asthma. Drugs (2004) 0.88
Etoricoxib. Drugs (2002) 0.88
Darifenacin: in the treatment of overactive bladder. Drugs Aging (2004) 0.88
Eptifibatide: a review of its use in patients with acute coronary syndromes and/or undergoing percutaneous coronary intervention. Drugs (2005) 0.88
Ranibizumab. Drugs (2007) 0.87
Recombinant factor VIIa (eptacog alfa): a review of its use in congenital hemophilia with inhibitors, acquired hemophilia, and other congenital bleeding disorders. BioDrugs (2008) 0.87
Prolonged-release nicotinic acid: a review of its use in the treatment of dyslipidaemia. Drugs (2005) 0.87
Celecoxib: a review of its use in the management of arthritis and acute pain. Drugs (2007) 0.87
Beclometasone dipropionate/formoterol: in an HFA-propelled pressurised metered-dose inhaler. Drugs (2006) 0.87
Quetiapine: a review of its use in the management of bipolar depression. CNS Drugs (2012) 0.87
Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder. Paediatr Drugs (2006) 0.86
Pegylated liposomal doxorubicin: a guide to its use in various malignancies. BioDrugs (2013) 0.86
Colesevelam: a review of its use in hypercholesterolemia. Am J Cardiovasc Drugs (2007) 0.86
Fenofibric acid: in combination therapy in the treatment of mixed dyslipidemia. Am J Cardiovasc Drugs (2009) 0.86
Sodium oxybate: a review of its use in the management of narcolepsy. CNS Drugs (2007) 0.85
Adalimumab: a review of its use in rheumatoid arthritis. BioDrugs (2004) 0.85
Bisoprolol: a review of its use in chronic heart failure. Drugs (2002) 0.85
Paliperidone extended release: a review of its use in the management of schizophrenia. Drugs (2010) 0.84
Mannitol dry powder for inhalation: in patients with cystic fibrosis. Drugs (2012) 0.84
Bevacizumab: in first-line treatment of advanced and/or metastatic renal cell carcinoma. BioDrugs (2008) 0.84
Bevacizumab plus platinum-based chemotherapy: in advanced non-small cell lung cancer. BioDrugs (2009) 0.84
Enfuvirtide: a review of its use in the management of HIV infection. Drugs (2005) 0.84